Correlation Between Eyenovia and Immix Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Immix Biopharma, you can compare the effects of market volatilities on Eyenovia and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Immix Biopharma.

Diversification Opportunities for Eyenovia and Immix Biopharma

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Eyenovia and Immix is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Eyenovia i.e., Eyenovia and Immix Biopharma go up and down completely randomly.

Pair Corralation between Eyenovia and Immix Biopharma

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Immix Biopharma. In addition to that, Eyenovia is 3.83 times more volatile than Immix Biopharma. It trades about -0.24 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.05 per unit of volatility. If you would invest  163.00  in Immix Biopharma on August 24, 2024 and sell it today you would earn a total of  5.00  from holding Immix Biopharma or generate 3.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Immix Biopharma

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Immix Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immix Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Eyenovia and Immix Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Immix Biopharma

The main advantage of trading using opposite Eyenovia and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.
The idea behind Eyenovia and Immix Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk